The company's facility in Bengaluru underwent a United States Food and Drug Administration (USFDA) inspection that ended on May 24, 2019, Strides Pharma Science said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XUqVUL
via IFTTT
0 comments:
Post a Comment